Literature DB >> 32597503

Melatonin restores neutrophil functions and prevents apoptosis amid dysfunctional glutathione redox system.

Somanathapura K NaveenKumar1, Mahadevappa Hemshekhar1, Swamy Jagadish1, Kurnegala Manikanta1, Gopalapura J Vishalakshi1, Kempaiah Kemparaju1, Kesturu S Girish1,2.   

Abstract

Melatonin is a chronobiotic hormone, which can regulate human diseases like cancer, atherosclerosis, respiratory disorders, and microbial infections by regulating redox system. Melatonin exhibits innate immunomodulation by communicating with immune system and influencing neutrophils to fight infections and inflammation. However, sustaining redox homeostasis and reactive oxygen species (ROS) generation in neutrophils are critical during chemotaxis, oxidative burst, phagocytosis, and neutrophil extracellular trap (NET) formation. Therefore, endogenous antioxidant glutathione (GSH) redox cycle is highly vital in regulating neutrophil functions. Reduced intracellular GSH levels and glutathione reductase (GR) activity in the neutrophils during clinical conditions like autoimmune disorders, neurological disorders, diabetes, and microbial infections lead to dysfunctional neutrophils. Therefore, we hypothesized that redox modulators like melatonin can protect neutrophil health and functions under GSH and GR activity-deficient conditions. We demonstrate the dual role of melatonin, wherein it protects neutrophils from oxidative stress-induced apoptosis by reducing ROS generation; in contrast, it restores neutrophil functions like phagocytosis, degranulation, and NETosis in GSH and GR activity-deficient neutrophils by regulating ROS levels both in vitro and in vivo. Melatonin mitigates LPS-induced neutrophil dysfunctions by rejuvenating GSH redox system, specifically GR activity by acting as a parallel redox system. Our results indicate that melatonin could be a potential auxiliary therapy to treat immune dysfunction and microbial infections, including virus, under chronic disease conditions by restoring neutrophil functions. Further, melatonin could be a promising immune system booster to fight unprecedented pandemics like the current COVID-19. However, further studies are indispensable to address the clinical usage of melatonin.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  2-AAPA; BSO; NETosis; glutathione; glutathione reductase; melatonin; neutrophil apoptosis; neutrophil functions

Mesh:

Substances:

Year:  2020        PMID: 32597503     DOI: 10.1111/jpi.12676

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  13 in total

1.  Melatonin inhibits Gram-negative pathogens by targeting citrate synthase.

Authors:  Fang He; Yuan Liu; Pan Li; Xiaoyan Wu; Yaoyao Xia; Dong Zhang; Nengzhang Li; Yuanyi Peng; Guoqiang Zhu; Rüdiger Hardeland; Russel J Reiter; Wenkai Ren
Journal:  Sci China Life Sci       Date:  2022-01-05       Impact factor: 10.372

Review 2.  Neutrophil Functional Heterogeneity and Implications for Viral Infections and Treatments.

Authors:  Lily Chan; Solmaz Morovati; Negar Karimi; Kasra Alizadeh; Sierra Vanderkamp; Julia E Kakish; Byram W Bridle; Khalil Karimi
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

3.  New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment.

Authors:  Virna Margarita Martín Giménez; Natalia Prado; Emiliano Diez; Walter Manucha; Russel J Reiter
Journal:  Nanomedicine (Lond)       Date:  2020-12-03       Impact factor: 5.307

Review 4.  Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.

Authors:  Michele Fresneda Alarcon; Zoe McLaren; Helen Louise Wright
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 8.786

5.  Neutrophil-derived heparin binding protein triggers vascular leakage and synergizes with myeloperoxidase at the early stage of severe burns (With video).

Authors:  Lu Liu; Yiming Shao; Yixuan Zhang; Yunxi Yang; Jiamin Huang; Linbin Li; Ran Sun; Yuying Zhou; Yicheng Su; Bingwei Sun
Journal:  Burns Trauma       Date:  2021-09-17

Review 6.  Melatonin as the Cornerstone of Neuroimmunoendocrinology.

Authors:  Igor Kvetnoy; Dmitry Ivanov; Ekaterina Mironova; Inna Evsyukova; Ruslan Nasyrov; Tatiana Kvetnaia; Victoria Polyakova
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 7.  Circadian regulation of innate immunity in animals and humans and implications for human disease.

Authors:  Joanna Poole; Gareth B Kitchen
Journal:  Semin Immunopathol       Date:  2022-02-15       Impact factor: 9.623

8.  Melatonin as an immunomodulator in children with Down syndrome.

Authors:  Dean Huggard; Lynne Kelly; Amy Worrall; Eleanor Gallagher; Lida Fallah; Lucas Lu Yoo; Fiona McGrane; Niamh Lagan; Edna Roche; Joanne Balfe; Derek G Doherty; Eleanor J Molloy
Journal:  Pediatr Res       Date:  2021-08-16       Impact factor: 3.953

Review 9.  Melatonin in Early Treatment for COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.

Authors:  Kristina M Cross; Dylan M Landis; Laveena Sehgal; J Drew Payne
Journal:  Endocr Pract       Date:  2021-06-10       Impact factor: 3.443

Review 10.  The Potentials of Melatonin in the Prevention and Treatment of Bacterial Meningitis Disease.

Authors:  Dong Zhang; Shu Xu; Yiting Wang; Guoqiang Zhu
Journal:  Molecules       Date:  2021-03-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.